Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
8004 | 1228 | 42.5 | 92% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
128 | 23028 | EPENDYMOMA//MEDULLOBLASTOMA//GLIOBLASTOMA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | IDH1 | Author keyword | 149 | 64% | 12% | 147 |
2 | IDH2 | Author keyword | 53 | 66% | 4% | 49 |
3 | ISOCITRATE DEHYDROGENASE 1 | Author keyword | 44 | 77% | 2% | 30 |
4 | MGMT | Author keyword | 37 | 24% | 11% | 137 |
5 | IDH | Author keyword | 33 | 53% | 4% | 43 |
6 | 2 HYDROXYGLUTARATE | Author keyword | 29 | 72% | 2% | 23 |
7 | IDH1 MUTATION | Author keyword | 24 | 61% | 2% | 25 |
8 | ISOCITRATE DEHYDROGENASE 2 | Author keyword | 22 | 81% | 1% | 13 |
9 | IDH MUTATION | Author keyword | 19 | 74% | 1% | 14 |
10 | G CIMP | Author keyword | 18 | 89% | 1% | 8 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | IDH1 | 149 | 64% | 12% | 147 | Search IDH1 | Search IDH1 |
2 | IDH2 | 53 | 66% | 4% | 49 | Search IDH2 | Search IDH2 |
3 | ISOCITRATE DEHYDROGENASE 1 | 44 | 77% | 2% | 30 | Search ISOCITRATE+DEHYDROGENASE+1 | Search ISOCITRATE+DEHYDROGENASE+1 |
4 | MGMT | 37 | 24% | 11% | 137 | Search MGMT | Search MGMT |
5 | IDH | 33 | 53% | 4% | 43 | Search IDH | Search IDH |
6 | 2 HYDROXYGLUTARATE | 29 | 72% | 2% | 23 | Search 2+HYDROXYGLUTARATE | Search 2+HYDROXYGLUTARATE |
7 | IDH1 MUTATION | 24 | 61% | 2% | 25 | Search IDH1+MUTATION | Search IDH1+MUTATION |
8 | ISOCITRATE DEHYDROGENASE 2 | 22 | 81% | 1% | 13 | Search ISOCITRATE+DEHYDROGENASE+2 | Search ISOCITRATE+DEHYDROGENASE+2 |
9 | IDH MUTATION | 19 | 74% | 1% | 14 | Search IDH+MUTATION | Search IDH+MUTATION |
10 | G CIMP | 18 | 89% | 1% | 8 | Search G+CIMP | Search G+CIMP |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CODON 132 MUTATION | 199 | 81% | 10% | 121 |
2 | IDH2 MUTATIONS | 103 | 48% | 13% | 159 |
3 | ISOCITRATE DEHYDROGENASE 1 | 99 | 65% | 8% | 94 |
4 | IDH1 MUTATIONS | 72 | 64% | 6% | 70 |
5 | MUTANT IDH1 | 64 | 88% | 2% | 30 |
6 | INTEGRATED GENOMIC ANALYSIS | 63 | 40% | 10% | 123 |
7 | 2 HYDROXYGLUTARATE | 58 | 72% | 4% | 46 |
8 | CODON 132 | 58 | 92% | 2% | 23 |
9 | ONCOMETABOLITE 2 HYDROXYGLUTARATE | 55 | 58% | 5% | 62 |
10 | DIFFUSE GLIOMAS | 41 | 57% | 4% | 48 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Molecular Pathways in Gliomagenesis and Their Relevance to Neuropathologic Diagnosis | 2015 | 5 | 66 | 68% |
Clinical impact of molecular biomarkers in gliomas | 2015 | 3 | 73 | 67% |
Specific monoclonal antibodies against IDH1/2 mutations as diagnostic tools for gliomas | 2015 | 2 | 76 | 89% |
The Definition of Primary and Secondary Glioblastoma | 2013 | 85 | 85 | 60% |
New Developments in the Pathogenesis and Therapeutic Targeting of the IDH1 Mutation in Glioma | 2015 | 2 | 98 | 50% |
Molecular Genetics of Gliomas | 2014 | 13 | 54 | 69% |
Oncogenic Isocitrate Dehydrogenase Mutations: Mechanisms, Models, and Clinical Opportunities | 2013 | 50 | 66 | 67% |
Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge | 2014 | 29 | 217 | 33% |
MGMT testing-the challenges for biomarker-based glioma treatment | 2014 | 18 | 91 | 45% |
Using the molecular classification of glioblastoma to inform personalized treatment | 2014 | 22 | 140 | 38% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CLIN COOPERAT UNIT NEUROPATHOL | 10 | 22% | 3.5% | 43 |
2 | SERV NEUROL MAZARIN 2 | 10 | 54% | 1.1% | 13 |
3 | CLIN COOPERAT UNIT NEUROONCOL | 6 | 28% | 1.5% | 18 |
4 | BRAIN TUMOR TRANSLAT | 6 | 47% | 0.7% | 9 |
5 | CLIN COOPERAT UNIT NEUROPATHOL G380 | 6 | 47% | 0.7% | 9 |
6 | PEDIAT BRAIN TUMOR FDN | 5 | 40% | 0.8% | 10 |
7 | DKTK CLIN COOPERAT UNIT NEUROIMMUNOL BRAIN TUMO | 4 | 75% | 0.2% | 3 |
8 | REG INNOVAT STRATEGY SUPPORT PROGRAM | 4 | 75% | 0.2% | 3 |
9 | MOL TUMOR MARKER TEAM | 3 | 50% | 0.4% | 5 |
10 | DANIEL DE HOED CANC ERASMUS | 3 | 100% | 0.2% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000267717 | OLIGODENDROGLIOMA//OLIGOASTROCYTOMA//19Q |
2 | 0.0000209578 | BRAIN TUMOR STEM CELL//GLIOMA STEM CELLS//BRAIN TUMOR STEM CELLS |
3 | 0.0000191848 | EGFRVIII//RECURRENT GLIOBLASTOMA//TUMOR TREATING FIELDS |
4 | 0.0000156668 | NEUROTRAUMA VARIAT REGENERAT//TIANTAN HOSP//OTORHINOLARYNGOL MAXILLO IAL ONCOL |
5 | 0.0000152078 | TEMOZOLOMIDE//GLIOBLASTOMA MULTIFORME//ANAPLASTIC ASTROCYTOMA |
6 | 0.0000146597 | MAZUMDAR SHAW TRANSLAT//2 DIMENSIONAL LIQUID CHROMATOGRAPHY//BIOLOGICAL VARIATION ANALYSIS |
7 | 0.0000096898 | L 2 HYDROXYGLUTARIC ACIDURIA//GLUTARIC ACIDURIA TYPE I//GLUTARIC ACIDURIA TYPE 1 |
8 | 0.0000090282 | EVOLUT CANC//PETOS PARADOX//TRANSLAT CANC THER EUT |
9 | 0.0000083796 | DIFFUSE INTRINSIC PONTINE GLIOMA//BRAINSTEM GLIOMA//PONTINE GLIOMA |
10 | 0.0000083688 | 5 HYDROXYMETHYLCYTOSINE//5HMC//5 CARBOXYLCYTOSINE |